Kurzfassung

Multicenter, randomized study to evaluate the efficacy and safety of
Bevacizumab in combination with Letrozole compared to Letrozole
alone, in postmenopausal women with advanced or metastatic cancer
with indication of hormontherapy as first-line treatment